About John Vroom
Form D filings for Kano Therapeutics in 2024 list John Vroom as director.
John Vroom first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Vroom in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Vroom works with at each company, as listed on that company's latest Form D.
Kano Therapeutics Inc. · Form D, May 20, 2024
AD
Ann DeWitt
Director
FE
Floris Engelhardt
Chief Executive Officer and director